MUSTANG BIO, INC. Payments of Stock Issuance Costs
MUSTANG BIO, INC. (MBIO) reported Payments of Stock Issuance Costs of $1.35 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2025-03-28
- MUSTANG BIO, INC. payments of stock issuance costs for the quarter ending 2024-12-31 was $569.00K, a 29.32% increase year-over-year.
- MUSTANG BIO, INC. payments of stock issuance costs for the quarter ending 2024-09-30 was $104.00K, a 3366.67% increase year-over-year.
- MUSTANG BIO, INC. payments of stock issuance costs for the quarter ending 2023-12-31 was $440.00K.
- MUSTANG BIO, INC. payments of stock issuance costs for the quarter ending 2023-09-30 was $3.00K.
- MUSTANG BIO, INC. payments of stock issuance costs for fiscal 2024 was $1.35M, a 205.42% increase from fiscal 2023.
- MUSTANG BIO, INC. payments of stock issuance costs for fiscal 2023 was $443.00K.
- MUSTANG BIO, INC. payments of stock issuance costs for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- MUSTANG BIO, INC. payments of stock issuance costs for fiscal 2020 was $2.39M, a 14.37% increase from fiscal 2019.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 7 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 9 month as first filed | Payments of Stock Issuance Costs 10 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | $569.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $673.00K derived: sum of 2 quarters · filed 2025-03-28 | $1.35M 10-K · filed 2025-03-28 | ||||
| 2024-09-30 | $104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $784.00K 10-Q · filed 2024-11-08 | |||||
| 2024-06-30 | $680.00K 10-Q · filed 2024-08-13 | ||||||
| 2023-12-31 | $440.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $443.00K derived: sum of 2 quarters · filed 2025-03-28 | $443.00K 10-K · filed 2025-03-28 | ||||
| 2023-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $3.00K 10-Q · filed 2024-11-08 | |||||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-13 | ||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $0.00 derived: sum of 2 quarters · filed 2022-03-23 | $0.00 10-K · filed 2022-03-23 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | |||||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | ||||||
| 2020-12-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $154.00K derived: sum of 2 quarters · filed 2022-03-23 | $2.39M 10-K · filed 2022-03-23 | ||||
| 2020-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $2.28M 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | $2.23M 10-Q · filed 2021-08-16 | ||||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | -$52.00K derived: sum of 2 quarters · filed 2021-03-24 | $2.09M 10-K · filed 2021-03-24 | ||||
| 2019-09-30 | -$52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $2.09M 10-Q · filed 2020-11-06 | |||||
| 2019-06-30 | $2.14M 10-Q · filed 2020-08-10 | ||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $0.00 derived: sum of 2 quarters · filed 2020-03-16 | $0.00 derived: sum of 3 quarters · filed 2020-03-16 | $0.00 10-K · filed 2020-03-16 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $0.00 10-Q · filed 2018-08-13 | $0.00 derived: sum of 3 quarters · filed 2019-03-18 | $3.00K derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-14 | $0.00 derived: sum of 2 quarters · filed 2019-03-18 | $3.00K derived: sum of 3 quarters · filed 2019-03-18 | $11.00K derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $3.00K derived: sum of 2 quarters · filed 2019-03-18 | $11.00K derived: sum of 3 quarters · filed 2019-03-18 | $5.67M 10-K · filed 2019-03-18 | |||
| 2017-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $11.00K derived: sum of 2 quarters · filed 2018-11-13 | $5.67M 10-Q · filed 2018-11-13 | $9.76M derived: sum of 4 quarters · filed 2018-11-13 | |||
| 2017-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $5.67M 10-Q · filed 2018-08-13 | $9.76M derived: sum of 3 quarters · filed 2018-08-13 | $9.76M derived: sum of 4 quarters · filed 2018-08-13 | |||
| 2017-03-31 | $5.66M 10-Q · filed 2018-05-14 | $9.75M derived: sum of 2 quarters · filed 2018-05-14 | $9.75M derived: sum of 3 quarters · filed 2018-05-14 | $9.75M derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-12-31 | $4.09M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $4.09M derived: sum of 2 quarters · filed 2018-03-29 | $4.09M derived: sum of 3 quarters · filed 2018-03-29 | $4.09M 10-K · filed 2018-03-29 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 | $1.36M 10-Q · filed 2016-11-14 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | |||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-15 | ||||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-29 | $0.00 10-K · filed 2017-03-31 | |||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |